ResMed Inc (BSP:R1MD34)
R$ 371.16 0 (0%) Market Cap: 217.94 Bil Enterprise Value: 220.49 Bil PE Ratio: 33.02 PB Ratio: 7.04 GF Score: 85/100

Resmed Inc at William Blair Growth Stock Conference (Virtual) Transcript

Jun 01, 2021 / 06:20PM GMT
Release Date Price: R$258
Malgorzata Maria Kaczor Andrew
William Blair & Company L.L.C., Research Division - Partner

Hey, good afternoon, everyone. My name is Margaret Kaczor. I am the research analyst here at William Blair & Company who covers ResMed. I am required to inform you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com. Now because the conference is, unfortunately, still virtual this year, we are going to keep this to a fireside chat.

So we're going to go for some of the company basics, some recent updates, as well as some more future outlook details. There is a way to send us some questions online. So feel free to submit those, and I will certainly ask them as they come up. But with that, we're very pleased to have Rob Douglas, President and COO of ResMed with us. Rob, thanks for joining us.

Robert A. Douglas
ResMed Inc. - President & COO

Yes. Thanks, Margaret. Just by way of quick introduction, we announced our results about a month ago now. So that's where we are. Basically, that was a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot